Drug abuse itself is not classified as a mental illness, but it can develop into one. When drug use becomes compulsive and continues despite serious harm, it crosses into a diagnosable condition called substance use disorder. This is recognized as a mental health condition in the same diagnostic manual that psychiatrists use to diagnose depression, anxiety, PTSD, and every other mental illness.
The distinction matters. Trying drugs, using them recreationally, or even misusing them occasionally does not automatically mean you have a mental illness. But repeated use changes the brain in ways that can make the behavior compulsive rather than voluntary, and that’s the point where it becomes a clinical disorder.
What Makes It a Diagnosable Condition
The Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR), the standard reference for psychiatric diagnosis in the United States, lists 11 criteria for substance use disorder. You don’t need to meet all of them. Meeting just 2 or 3 qualifies as a mild disorder, 4 or 5 as moderate, and 6 or more as severe.
The criteria fall into a few categories. Some involve losing control: using more than you intended, wanting to cut back but failing, spending large amounts of time obtaining or recovering from the substance, or experiencing strong cravings. Others involve consequences: dropping social, recreational, or work activities because of use, or continuing to use even when you know it’s causing physical or psychological problems. A third set is pharmacological: developing tolerance (needing more to get the same effect) and experiencing withdrawal symptoms when you stop.
What’s notable about this list is that it doesn’t require a rock-bottom moment or a dramatic crisis. Someone who meets two criteria, like repeatedly using more than planned and failing to cut back, already qualifies for a mild substance use disorder.
How Drugs Change the Brain
The core reason addiction is classified as a brain disorder rather than a moral failing comes down to what drugs physically do to the brain over time. Most drugs flood the brain’s reward system with dopamine, the chemical messenger tied to pleasure and motivation. That initial surge is what produces the high.
With repeated use, the brain adapts. It produces less dopamine on its own or becomes less sensitive to it, which is why the same dose stops working as well over time. This is tolerance, and it’s not just a subjective feeling. It reflects measurable changes in brain chemistry. The brain also starts linking the drug to environmental cues, like certain people, places, or emotions, creating powerful automatic urges that can persist long after someone decides they want to quit.
The progression follows a recognizable pattern in the brain. Early use is driven by the reward system: the drug feels good, so you seek it out. Over time, control shifts to brain regions responsible for habits, making drug-seeking increasingly automatic rather than deliberate. Meanwhile, the parts of the brain responsible for decision-making, judgment, and impulse control become impaired. This is why people continue using drugs even when they can clearly see the damage, and why willpower alone is rarely enough to stop.
Stress creates its own vulnerability. The brain has dedicated circuits that can trigger relapse in response to stress, even after long periods without using. One of these circuits runs through the amygdala, a brain region involved in fear and emotional responses, and uses stress hormones as its chemical signal. This helps explain why stressful life events are one of the most common triggers for relapse.
Why It Runs in Families
Genetics account for roughly 50% of a person’s risk of developing a substance use disorder. That number is consistent across different substances: alcohol use disorder shows heritability of about 50 to 64%, opioid use disorder around 50%, and cannabis use disorder between 51 and 59%. Cocaine use disorder has the widest range, with estimates from 40 to 80%.
This doesn’t mean addiction is predetermined. It means some people are born with brain chemistry that makes them more vulnerable to the effects of drugs. The other half of the risk comes from environment: childhood trauma, exposure to substance use, stress, peer influence, and access. Adverse childhood experiences like abuse, neglect, and household dysfunction are strongly linked to substance misuse in adulthood. Having a genetic predisposition and a difficult environment creates compounding risk.
The Brain Can Recover
One of the most important things to understand about substance use disorder is that the brain changes are not necessarily permanent. Research using brain imaging has tracked recovery during abstinence, and the results are encouraging, though the timeline varies.
Structural brain recovery tends to begin relatively quickly. In people with alcohol use disorder, key brain chemicals in the frontal cortex start normalizing within the first month of abstinence. Certain neurotransmitter levels that drop during heavy use can return to normal within about four weeks. Dopamine function in smokers, which is 15 to 20% lower than in nonsmokers, has been shown to normalize after three months without nicotine.
Other systems take longer. Dopamine transporter levels in the brains of heroin users required 6 to 12 months of abstinence to recover. Some receptor systems in the brain take six months or more to show significant improvement. The general pattern is that structural recovery happens first, followed by chemical recovery, with full functional recovery potentially requiring the longest period of sustained abstinence.
This timeline is one reason addiction is described as a chronic, relapsing condition. People in recovery remain at elevated risk for returning to drug use even after years, because some brain changes persist and because the learned associations between environmental cues and drug use can be reactivated. That said, relapse is not inevitable, and longer periods of abstinence are associated with progressively greater brain recovery.
How It Overlaps With Other Mental Health Conditions
Substance use disorders frequently co-occur with other mental health conditions like depression, anxiety, PTSD, and bipolar disorder. This is common enough that clinicians have a term for it: co-occurring disorders, or dual diagnosis. The relationship runs in both directions. People with existing mental health conditions may use substances to self-medicate, and chronic substance use can trigger or worsen psychiatric symptoms.
Effective treatment addresses both conditions at the same time. For substance use disorders specifically, evidence-based approaches combine behavioral therapies with medications when appropriate. Medications can reduce cravings, ease withdrawal, or block the rewarding effects of a substance. Behavioral therapies help people recognize triggers, develop coping strategies, and rebuild the decision-making skills that addiction erodes. Neither approach alone is as effective as the combination.
Choice vs. Disease: Why the Debate Persists
The idea that addiction is a disease still meets resistance, partly because the first use is almost always voluntary. Nobody develops a substance use disorder without choosing to try a drug at some point. This makes it easy to frame the entire process as a series of bad decisions.
But the same logic could apply to many chronic diseases. Type 2 diabetes often involves dietary choices. Heart disease is influenced by lifestyle. The fact that behavior contributes to a condition doesn’t disqualify it as a medical disorder. What defines addiction as a disease is that it produces measurable, lasting changes in brain structure and function that impair a person’s ability to control their behavior. The initial choice is voluntary. The compulsion that follows is not.
The National Institute on Drug Abuse defines addiction as “a chronic disease characterized by drug seeking and use that is compulsive, or difficult to control, despite harmful consequences.” This framing isn’t about removing personal responsibility. It’s about accurately describing what happens in the brain and ensuring that people with substance use disorders have access to medical treatment rather than only facing punishment.